Radiopharmaceutical in Management of Parkinsonism

Radiopharmaceutical in Management of Parkinsonism

A Diagnostic Approach

Versandkostenfrei!
Versandfertig in 6-10 Tagen
32,99 €
inkl. MwSt.
PAYBACK Punkte
16 °P sammeln!
The research work in this book was carried out at Radiopharmaceutical division of Bhabha Atomic Research Centre, Mumbai. Radiolabelling of MAO inhibitor drug harmalol with iodine-125 was carried out and evaluated in the management of Parkinson s disease with the aim of its potential application as a diagnostic radiopharmaceutical. This book has been of great value for the students, academicians and researchers in the field of Pharmacy, Radiology, Pharmacology and medical sciences.